Sanofi (SAN) Given a €82.00 Price Target by HSBC Analysts

HSBC set a €82.00 ($95.35) target price on Sanofi (EPA:SAN) in a research note published on Thursday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

Other research analysts have also issued research reports about the stock. UBS Group set a €79.00 ($91.86) price objective on shares of Sanofi and gave the stock a neutral rating in a research note on Friday, April 26th. JPMorgan Chase & Co. set a €81.00 ($94.19) price objective on shares of Sanofi and gave the stock a neutral rating in a research note on Monday, April 29th. Goldman Sachs Group set a €77.00 ($89.53) price objective on shares of Sanofi and gave the stock a neutral rating in a research note on Thursday, April 11th. Credit Suisse Group set a €82.00 ($95.35) price objective on shares of Sanofi and gave the stock a buy rating in a research note on Friday, February 8th. Finally, Deutsche Bank set a €93.00 ($108.14) price objective on shares of Sanofi and gave the stock a buy rating in a research note on Friday, February 8th. Six analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The company presently has an average rating of Buy and an average price target of €85.53 ($99.46).

EPA SAN opened at €72.72 ($84.56) on Thursday. Sanofi has a 52 week low of €63.09 ($73.36) and a 52 week high of €92.97 ($108.10).

About Sanofi

Sanofi provides therapeutic solutions. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; Aubagio, an immunomodulatory; and Lemtrada, a monoclonal antibody to treat multiple sclerosis.

Featured Article: What is a short straddle?

Analyst Recommendations for Sanofi (EPA:SAN)

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.